19 related articles for article (PubMed ID: 32552947)
1.
Liu Z; Li S; Guo W; Wang Y; Wang M; Bai O
Biomed Res Int; 2017; 2017():1967648. PubMed ID: 29209623
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and prognostic analysis of relapsed/refractory diffuse large B-cell lymphoma patients with hepatitis B virus infection].
Fang Y; Wang L; Qian Y; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):1017-1020. PubMed ID: 30612404
[No Abstract] [Full Text] [Related]
3. Performance of the cobas EZH2 mutation test on clinical samples from non-Hodgkin lymphoma patients.
Shyu JY; Schlag PA; Karwowska SM; Manohar CF; Truong HM; Longshore JW; Zhang G
PLoS One; 2023; 18(12):e0292251. PubMed ID: 38096164
[TBL] [Abstract][Full Text] [Related]
4. Role of virological serum markers in patients with both hepatitis B virus infection and diffuse large B-cell lymphoma.
Zhou X; Wuchter P; Egerer G; Kriegsmann M; Mataityte A; Koelsche C; Witzens-Harig M; Kriegsmann K
Eur J Haematol; 2019 Oct; 103(4):410-416. PubMed ID: 31338887
[TBL] [Abstract][Full Text] [Related]
5. Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.
Guo W; Zhang W; Liu C; Song Y; Bai O
PLoS One; 2015; 10(6):e0129064. PubMed ID: 26053951
[TBL] [Abstract][Full Text] [Related]
6. Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study.
Huang HH; Hsiao FY; Chen HM; Wang CY; Ko BS
Br J Haematol; 2021 Jan; 192(1):110-118. PubMed ID: 33131074
[TBL] [Abstract][Full Text] [Related]
7. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
8. Short-term efficacy of rituximab-CHOP and CHOP regimens on two subtypes of diffuse large B-cell lymphoma.
Xia Y; Li ZM; Shi YX; Xia ZJ; Jiang WQ; Huang HQ
Ai Zheng; 2009 Feb; 28(2):146-9. PubMed ID: 19550126
[TBL] [Abstract][Full Text] [Related]
9. [Expression and Clinical Significance of EZH2 in Patients with Diffuse Large B Cell Lymphoma Accompanied by HBV Infection].
Zhang YT; Feng D; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):855-860. PubMed ID: 32552947
[TBL] [Abstract][Full Text] [Related]
10. HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy.
Wan X; Young KH; Bai O
Front Immunol; 2023; 14():1216610. PubMed ID: 37483605
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
